Original Research

Published on 27 Oct 2022

Ultrastructural analysis of zinc oxide nanospheres enhances anti-tumor efficacy against Hepatoma

in Pharmacology of Anti-Cancer Drugs

Amr Hassan
Fawziah A. Al-Salmi
Tamer M. M. Abuamara
Emadeldin R. Matar
Mohamed E. Amer
Ebrahim M. M. Fayed
Mohamed G. A. Hablas
Tahseen S. Mohammed
Haytham E. Ali
Fayez M. Abd EL-fattah

Frontiers in Oncology

doi 10.3389/fonc.2022.933750

4,278 views
9 citations

Perspective

Published on 26 Oct 2022

Early access provision: Awareness, educational needs and opportunities to improve oncology patients’ access to care

in Pharmacology of Anti-Cancer Drugs

Andriy Krendyukov
Sanjay Singhvi
Yianick Green-Morrison
Markus Zabransky

Frontiers in Oncology

doi 10.3389/fonc.2022.714516

1,965 views
2 citations

Editorial

Published on 25 Oct 2022

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs

in Pharmacology of Anti-Cancer Drugs

Yao Liu
Jennifer H. Martin
Miao Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.1053211

1,616 views
2 citations

Original Research

Published on 24 Oct 2022

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods

in Pharmacology of Anti-Cancer Drugs

Tianyang Zhou
Mengting Yang
Mijia Wang
Linlin Han
Hong Chen
Nan Wu
Shan Wang
Xinyi Wang
Yuting Zhang
Di Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.1046039

2,914 views
2 citations

Editorial

Published on 19 Oct 2022

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer

in Pharmacology of Anti-Cancer Drugs

Pasquale Pisapia
Zhi Li
Cyril Corbet

Frontiers in Oncology

doi 10.3389/fonc.2022.1035245

1,063 views

Original Research

Published on 18 Oct 2022

Proanthocyanidins-loaded complex coacervates-based drug delivery attenuates oral squamous cell carcinoma cells metastatic potential through down-regulating the Akt signaling pathway

in Pharmacology of Anti-Cancer Drugs

Ju-Fang Liu
Yinshen Wee
Shen-Dean Luo
Shwu-Fen Chang
Shihai Jia
Sheng-Wei Feng
Huei-Mei Huang
Jiann-Her Lin
Ching-Shuen Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1001126

1,720 views
2 citations

Original Research

Published on 18 Oct 2022

Different treatment regimens in breast cancer visceral crisis: A retrospective cohort study

in Pharmacology of Anti-Cancer Drugs

Ruohan Yang
Guanyu Lu
Zheng Lv
Lin Jia
Jiuwei Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.1048781

9,959 views
14 citations

Review

Published on 18 Oct 2022

A spotlight on alkaloid nanoformulations for the treatment of lung cancer

in Pharmacology of Anti-Cancer Drugs

Sindhoor S. M.
N. Raghavendra Naveen
GSN Koteswara Rao
Gopika Gopan
Hitesh Chopra
Moon Nyeo Park
Mohammed Merae Alshahrani
Jobin Jose
Talha Bin Emran
Bonglee Kim

Frontiers in Oncology

doi 10.3389/fonc.2022.994155

4,300 views
16 citations

Original Research

Published on 17 Oct 2022

Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Hongliang Huang
Yuexiang Dai
Yingying Duan
Zhongwen Yuan
Yanxuan Li
Maomao Zhang
Wenting Zhu
Hang Yu
Wenfei Zhong
Senling Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.1033044

4,522 views
6 citations

Review

Published on 14 Oct 2022

Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition

in Pharmacology of Anti-Cancer Drugs

Xirui Duan
Maochao Luo
Jian Li
Zhisen Shen
Ke Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.1008027

3,295 views
13 citations

Original Research

Published on 12 Oct 2022

Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC

in Pharmacology of Anti-Cancer Drugs

Rose-Laure Indorato
Salvatore DeBonis
Isabel Garcia-Saez
Dimitrios A. Skoufias

Frontiers in Oncology

doi 10.3389/fonc.2022.965455

1,641 views
2 citations

Review

Published on 12 Oct 2022

Mechanisms of venetoclax resistance and solutions

in Pharmacology of Anti-Cancer Drugs

Jiachen Liu
Yidong Chen
Lihua Yu
Lihua Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1005659

13,213 views
23 citations

Review

Published on 10 Oct 2022

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers

in Pharmacology of Anti-Cancer Drugs

Nadia Saoudi González
Florian Castet
Elena Élez
Teresa Macarulla
Josep Tabernero

Frontiers in Oncology

doi 10.3389/fonc.2022.1021772

2,704 views
4 citations

Original Research

Published on 10 Oct 2022

Global publication trends and research hotspots of curcumin application in tumor: A 20-year bibliometric approach

in Pharmacology of Anti-Cancer Drugs

Jun Zhang
Yanran Huang
Jingtao Xu
Runhan Zhao
Chuang Xiong
Jiwa Habu
Yuping Wang
Xiaoji Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1033683

2,664 views
11 citations

Original Research

Published on 06 Oct 2022

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms

in Pharmacology of Anti-Cancer Drugs

Jakub Szymczyk
Martyna Sochacka
Patryk Chudy
Lukasz Opalinski
Jacek Otlewski
Malgorzata Zakrzewska

Frontiers in Oncology

doi 10.3389/fonc.2022.1011762

2,481 views
8 citations

Original Research

Published on 04 Oct 2022

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study

in Pharmacology of Anti-Cancer Drugs

Ryota Tashiro
Hitoshi Kawazoe
Kanako Mamishin
Keisuke Seto
Ryoko Udagawa
Yoshimasa Saito
Hironobu Hashimoto
Tatsunori Shimoi
Kan Yonemori
Masahito Yonemura

Frontiers in Oncology

doi 10.3389/fonc.2022.898150

4,011 views
4 citations

Navigation group

Articles

Ultrastructural analysis of zinc oxide nanospheres enhances anti-tumor efficacy against Hepatoma

Early access provision: Awareness, educational needs and opportunities to improve oncology patients’ access to care

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer

Proanthocyanidins-loaded complex coacervates-based drug delivery attenuates oral squamous cell carcinoma cells metastatic potential through down-regulating the Akt signaling pathway

Different treatment regimens in breast cancer visceral crisis: A retrospective cohort study

A spotlight on alkaloid nanoformulations for the treatment of lung cancer

Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer

Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition

Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC

Mechanisms of venetoclax resistance and solutions

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers

Global publication trends and research hotspots of curcumin application in tumor: A 20-year bibliometric approach

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study